Julie Magarian Blander received her Ph.D. from the University of Pittsburgh studying tumor immunology and immunotherapy under the mentorship of Olivera Finn. She conducted her postdoctoral training with Charles Janeway and Ruslan Medzhitov at Yale University pioneering the study of the impact of Toll-like receptors on macrophage and dendritic cell function. Dr. Blander became an Assistant Professor at the Icahn School of Medicine at Mount Sinai in 2006, an Associate Professor in 2011, and joined the faculty at Weill Cornell Medicine in 2016 as a Professor of Immunology in Medicine at the Jill Roberts Institute for Research in Inflammatory Bowel Disease. Dr. Blander has developed an Innate Immunity Research Program centered around the function of macrophages and dendritic cells in various settings of infection, cell death, autoimmunity, and cancer. Her laboratory has made major strides in understanding the innate immune response to microorganisms and apoptotic cells in the context of enteric infection, intestinal homeostasis, and malignant transformation. Dr. Blander is funded by the National Institutes of Health, the Leukemia and Lymphoma Society, and the Burroughs Wellcome Fund. She has received the Icahn School of Medicine Junior Faculty Award for Academic Excellence and the Harold and Golden Lamport Basic Research Award. She has been named Searle Scholar, American Cancer Society Research Scholar, J. V. Satterfield Arthritis Investigator, Irma T. Hirschl and Monique Weill-Caulier Scholar, and winner of the 2009 G. Jeanette Thorbecke award.
« Go Back